113 related articles for article (PubMed ID: 23620432)
1. Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression.
Mavridis K; Stravodimos K; Scorilas A
Prostate; 2013 Aug; 73(11):1191-201. PubMed ID: 23620432
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
Avgeris M; Stravodimos K; Scorilas A
Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Mavridis K; Avgeris M; Koutalellis G; Stravodimos K; Scorilas A
Cancer Sci; 2010 Mar; 101(3):693-9. PubMed ID: 20067463
[TBL] [Abstract][Full Text] [Related]
4. KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
Rabien A; Fritzsche FR; Jung M; Tölle A; Diamandis EP; Miller K; Jung K; Kristiansen G; Stephan C
Int J Cancer; 2010 Nov; 127(10):2386-94. PubMed ID: 20473923
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Yousef GM; Scorilas A; Katsaros D; Fracchioli S; Iskander L; Borgono C; Rigault de la Longrais IA; Puopolo M; Massobrio M; Diamandis EP
J Clin Oncol; 2003 Aug; 21(16):3119-26. PubMed ID: 12915603
[TBL] [Abstract][Full Text] [Related]
6. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
Yousef GM; Scorilas A; Magklara A; Memari N; Ponzone R; Sismondi P; Biglia N; Abd Ellatif M; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1294-300. PubMed ID: 12439720
[TBL] [Abstract][Full Text] [Related]
7. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues.
Papachristopoulou G; Avgeris M; Charlaftis A; Scorilas A
Thromb Haemost; 2011 Jan; 105(1):131-7. PubMed ID: 21057706
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
13. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of kallikrein 15 gene expression in prostate tissue.
Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Bharaj BS; Nakamura T; Loening SA; Diamandis E
J Urol; 2003 Jan; 169(1):361-4. PubMed ID: 12478190
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
[TBL] [Abstract][Full Text] [Related]
17. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
[TBL] [Abstract][Full Text] [Related]
18. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
Zhigang Z; Wenlu S
Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis.
Filippou PS; Ren AH; Soosaipillai A; Papaioannou MD; Korbakis D; Safar R; Diamandis EP; Conner JR
Clin Biochem; 2018 Sep; 59():78-85. PubMed ID: 29958881
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.
Korbakis D; Gregorakis AK; Scorilas A
Clin Chem; 2009 May; 55(5):904-13. PubMed ID: 19299547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
